Superbug drug recommended by EMA

Rosa Silverman,Pa
Friday 23 September 2011 15:50
Comments

A new drug that specifically targets hospital superbug Clostridium difficile while avoiding so-called "friendly" bacteria in the gut has been recommended by the European medicines supervisor.

It is hoped that Dificlir will improve the current treatment of the inflammation of the gut and severe diarrhoea caused by C. diff.

The European Medicines Agency (EMA) said the antibiotic should be authorised, a move they described as "a major step forward" in tackling the growing levels of resistance to available antibiotics across the European Union.

Infection with C. diff is a leading cause of disease in hospital, usually causing illness in patients who have been treated with other antibiotics, the EMA said.

But few acceptable treatments for C. diff are currently available, the agency added.

Because Dificlir targets C. diff specifically, its effect on other, beneficial bacteria in the gut is said to be minimal.

Dr Xavier Luria, the EMA's head of safety and efficacy, said: "This is a promising step forward in the agency's drive for addressing patients' needs in infectious diseases."

The drug is not currently licensed in the UK and is not used in British hospitals yet, the Medicines and Healthcare products Regulatory Agency said.

The European Commission will now make a decision on whether to authorise marketing of the drug.

PA

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in